A reporter screen of MECP2 turns up a regulatory variant that cuts expression about 30% in human neurons
Baylor researchers screened MECP2 regulatory regions in stem-cell-derived neurons and found one inherited variant that cut expression about 30%. The authors suggest it may explain part of autism's male skew and offer the assay as a template for other X-linked genes.
The Scientist · Science desk
Three figures. The variant leaves about 70% of normal MECP2 expression. Earlier mouse studies tie about 50% or less of normal to Rett syndrome, and a 30% expression cut to autism-like behaviors without seizures or motor problems.
| Figure | Value | Note | Claim |
|---|---|---|---|
| MECP2 expression left after the variant's cut, about | 70% of normal | 15 | |
| Rett level in mice, about | 50% or less | 8 | |
| Expression cut in mice tied to autism-like behaviors | 30% reduction | no seizures or motor problems | 9 |
What happened
- Screening autistic individuals turned up two regulatory regions where male autistic individuals had inherited, from an unaffected mother, a variant that altered regulatory activity.
- The screen was a massively parallel reporter assay run in neurons derived from induced pluripotent stem cells.
- Earlier mouse studies, as Meyer-Schuman described them, found that cutting expression 30% or raising it 50% brings autism-like behavior without seizures or motor problems.
- The work appeared in The American Journal of Human Genetics, with Huda Zoghbi as senior and corresponding author.
Why it matters
- constraint A 30% cut leaves about 70% of normal expression, 20 points above the 'about 50% or less' level tied to Rett syndrome, so this variant belongs to the mild end of the dosage range.
- constraint Unaffected carrier mothers are consistent with the second-X protection idea, but carrier mothers alone cannot show that the second X is what protects them.
- decision A group copying the design on another X-linked gene would first need that gene's dose range, because MECP2's known thresholds are what let a 30% change be read as mild.
MECP2 was a deliberate first choice. Rebecca Meyer-Schuman, a postdoctoral associate in the Zoghbi lab, said, "what better place to start looking at these regulatory regions than the gene MECP2, where brain health depends on how much of the gene is expressed, and where mutations can cause neurodevelopmental disorders that include autism." [7]
"We tested the idea that the predominance of autism in males could be explained in part by mild mutations in an X chromosome gene's regulatory regions," Meyer-Schuman said. [5] She added: "Females might be protected from such a mild mutation because of their second X chromosome, but males, who have only one copy, would be more vulnerable." [6]
"This allowed us to identify and manipulate the regulatory regions and determine what kinds of changes would alter their function," Meyer-Schuman said. [11] Variants found in autistic individuals were then tested in the same assay. [12]
The account does not say how many people sit behind the two regions, or how many autistic individuals were screened and variants tested. [13] The 30% drop was measured in human neurons. [14] The link from a drop of that size to autism-like behavior comes from mouse studies. [9]
The authors go further in the paper itself: "These findings suggest noncoding MECP2 variants can cause idiopathic, male-biased autism and provide a framework for uncovering regulatory variants in other X chromosome neurodevelopmental genes that may contribute to autism's missing heritability." [4] In our view, "can cause" rests on three links: a measured drop in expression in human neurons, an inheritance pattern, and mouse data tying that size of drop to behavior.
What to watch
- The number of autistic individuals screened and variants tested, and whether the two regions replicate in other autism cohorts.
- Whether the same reporter assay is run on a second X-linked neurodevelopmental gene, as the authors propose.
- A direct test of the 30%-reduction variant's effect on behavior in an animal model, which would replace the inference from earlier mouse dosage studies.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence45
- Adoption
- Insufficient
- Hype gap+15
- Incentives
- Insufficient
- Confidence50
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
Researchers at Baylor College of Medicine, the Duncan Neurological Research Institute at Texas Children's Hospital, and collaborating institutions identified new genetic candidates that help explain why autism is diagnosed about four times more often in boys than in girls.
- [2]
The study, which involved tests in induced pluripotent stem cell-derived neurons (iNeurons), found that small changes in the X-linked gene MECP2 might help explain part of the male-female difference in autism diagnosis.
- [3]
The paper, titled 'A massively parallel reporter assay of MECP2 cis-regulatory elements reveals genetic candidates for male-biased autism,' was published in The American Journal of Human Genetics, with Huda Zoghbi as senior and corresponding author.
- [4]
The authors wrote in the paper: "These findings suggest noncoding MECP2 variants can cause idiopathic, male-biased autism and provide a framework for uncovering regulatory variants in other X chromosome neurodevelopmental genes that may contribute to autism's missing heritability."
- [5]
Rebecca Meyer-Schuman said: "We tested the idea that the predominance of autism in males could be explained in part by mild mutations in an X chromosome gene's regulatory regions,"
- [6]
Meyer-Schuman said: "Females might be protected from such a mild mutation because of their second X chromosome, but males, who have only one copy, would be more vulnerable."
- [7]
Meyer-Schuman said: "what better place to start looking at these regulatory regions than the gene MECP2, where brain health depends on how much of the gene is expressed, and where mutations can cause neurodevelopmental disorders that include autism."
- [8]
Earlier murine studies by the Zoghbi lab and others showed MECP2 must stay at a 'just right' level: about 50% or less of normal levels leads to Rett syndrome, and twice the normal level causes MECP2 duplication syndrome.
- [9]
Meyer-Schuman said previous studies in mice showed that milder changes in MECP2 levels, such as reducing expression by 30% or increasing it by 50%, do not cause the more severe features of Rett syndrome or MECP2 duplication syndrome like seizures or motor problems, but lead to autism-like behaviors.
- [10]
The team used a massively parallel reporter assay (MPRA) to screen the regulatory regions of the MECP2 gene in iPSC-derived neurons.
- [11]
Meyer-Schuman said: "This allowed us to identify and manipulate the regulatory regions and determine what kinds of changes would alter their function,"
- [12]
The researchers also screened MECP2 regulatory regions in autistic individuals and tested the genetic variants they identified using the MPRA assays.
- [13]
Meyer-Schuman said the team identified two regulatory regions where male autistic individuals inherited a variant from their unaffected mother that altered regulatory activity.
- [14]
Meyer-Schuman said one of these variants reduced MECP2 expression by approximately 30% in human neurons.
- [15]
A roughly 30% reduction leaves about 70% of normal MECP2 expression.
- [16]
About 70% of normal expression is roughly 20 percentage points above the 'about 50% or less' level associated with Rett syndrome.
Sources
1 independent publisher whose own reporting we read for this story.
- genengnews.comX-Chromosome Gene Linked to Increased Autism Diagnosis in Males
1 article · October 13, 2026
Topics and entities
Follow any of these and your For You feed starts watching them — no settings page required.
Topics
- Gene regulationFollow
- Autism geneticsFollow
- Neurodevelopmental disordersFollow
Entities
- Huda ZoghbiFollow
- MECP2Follow
- Jan and Dan Duncan Neurological Research Institute at Texas Children's HospitalFollow
- The American Journal of Human GeneticsFollow
- Rebecca Meyer-SchumanFollow
- GEN (Genetic Engineering & Biotechnology News)Follow
- Baylor College of MedicineFollow